Tri Locum Partners »

United Therapeutics Corporation shares owned by Tri Locum Partners

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Tri Locum Partners from 13F filings

Historical chart of Tri Locum Partners investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Tri Locum Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Tri Locum Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $51M 122k 419.21
2024-09-30 $20M 55k 358.35
2024-06-30 $16M 50k 318.55
2021-12-31 $9.9M 46k 216.08
2021-09-30 $6.1M 33k 184.59

More positions owned by Tri Locum Partners

Johnson & Johnson (JNJ)
United Therapeutics Corporation (UTHR)
Merck & Co (MRK)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vera Therapeutics Cl A (VERA)
Argenx Se Sponsored Adr (ARGX)
Madrigal Pharmaceuticals (MDGL)
Soleno Therapeutics (SLNO)
Abbvie (ABBV)
Korro Bio (KRRO)
Xenon Pharmaceuticals (XENE)
Avadel Pharmaceuticals Com Shs (AVDL)
Stevanato Group S P A Ord Shs (STVN)
Dianthus Therapeutics (DNTH)

View all positions for Tri Locum Partners

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation